Qvella's Series B Round

Qvella raised a round of funding on December 04, 2017.

Qvella is a molecular diagnostics company that aims to reduce the time to results in the diagnosis of infections via technology for pathogen detection, which enables direct sampling of bodily fluids w…

Articles about Qvella's Series B Round: